Synapse - Works

Results (79)

Gene expression profiling identifies potential precursor genes in lobular carcinoma in situ

Meeting Abstract

Andrade, V. P.; Morrogh, M.; Qin, L. X.; Olvera, N.; Giri, D.; Brogi, E.; de Alcantara- Filho, P.; Paik, W.; Muhsen, S.; Morrow, M.; more...
Cancer Research (2010)

Fulltext@MSK | Save

CALGB 40302: Fulvestrant with or without lapatinib as therapy for hormone receptor positive advanced breast cancer: A double-blinded, placebo-controlled, randomized phase III study

Meeting Abstract

Burstein, H. J.; Barry, W. T.; Cirrincione, C.; Chew, H. K.; Tolaney, S.; Lake, D.; Pluard, T.; Blackwell, K.; Winer, E. P.; Hudis, C. A.
Cancer Research (2010)

Fulltext@MSK | Save

Administration of the novel antiangiogenic PTC299 in combination with aromatase inhibitors is feasible and shows antitumor activity in metastatic breast cancer

Meeting Abstract

Tiersten, A.; Schneider, B. P.; Dickler, M.; Volm, M.; Speyer, J.; Novik, Y.; Lehman, R.; Callahan, L. A.; Darby, C. H.; Miller, L. L.; more...
Cancer Research (2010)

Fulltext@MSK | Save

Combination of tivozanib, an oral inhibitor of VEGFR, with weekly paclitaxel for metastatic breast cancer: Preliminary results of an ongoing phase 1 study

Meeting Abstract

Mayer, E. L.; Scheulen, M.; Beckman, J.; Richly, H.; Poli, A.; Bhargava, P.; Duarte, A.; Cotreau, M.; Al-Adhami, M.; Dickler, M.
Cancer Research (2010)

Fulltext@MSK | Save

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions: Analysis of fresh frozen tissue using SNP array

Meeting Abstract

Andrade, V. P.; Morrogh, M.; Giri, D.; Ostrovnaya, I.; Seshan, V.; Olvera, N.; Begg, C.; Morrow, M.; King, T. A.
Cancer Research (2010)

Fulltext@MSK | Save

Phase 1 dose-escalation study of the heat shock protein 90 inhibitor BIIB021 with trastuzumab in HER2+ metastatic breast cancer

Meeting Abstract

Modi, S.; Ismail-Khan, R.; Munster, P.; Lucas, M.; Galluppi, G. R.; Tangri, S.; Chen, Y.; Yamashita, M.; Storgard, C. M.; Moulder, S.
Cancer Research (2010)

Fulltext@MSK | Save

A dose-escalation study of trastuzumab-DM1 (T-DM1), paclitaxel (T), and pertuzumab (P) in patients with HER2-positive, locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen

Meeting Abstract

Krop, I. E.; Modi, S.; Elias, A.; LoRusso, P.; Choi, Y. J.; Lu, M.
Cancer Research (2010)

Fulltext@MSK | Save

Pharmacokinetics (PK) of trastuzumab-DM1 (T-DM1) and paclitaxel (T) in patients with HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen

Meeting Abstract

Lu, D.; Krop, I.; Modi, S.; Elias, A.; LoRusso, P.; Huang, J.; Lu, M.; Girish, S.
Cancer Research (2010)

Fulltext@MSK | Save

Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: A phase II trial of three dimensional conformal radiation therapy (3DCRT) partial breast irradiation (PBI) following lumpectomy for stage I and II breast cancer

Meeting Abstract

Chafe, S. J.; Moughan, J.; Vicini, F. A.; Wong, J. W. C.; Pass, H. A.; Rabinovich, R. A.; Arthur, D. W.; Petersen, I. A.; White, J. R.; McCormick, B.
Cancer Research (2010)

Fulltext@MSK | Save

Symptomatic congestive heart failure after neo/adjuvant dose-dense epirubicin: A retrospective analysis of two trials with long-term follow-up

Meeting Abstract

Gajria, D.; Pokuri, V.; Steingart, R.; Hudis, C.; Dang, C.
Cancer Research (2010)

Fulltext@MSK | Save